The antiepidermal growth factor receptor agent gefitinib (ZD1839/Iressa) improves antihormone response and prevents development of resistance in breast cancer in vitro
Endocrinology (2003) - Comment
pubmed: 12960029  doi: 10.1210/en.2003-0705  issn: 0013-7227  issn: 1945-7170 

J. M. W. Gee, M. E. Harper, I. R. Hutcheson, T. A. Madden, D. Barrow, J. M. Knowlden, R. A. McClelland, N. Jordan, A. E. Wakeling, R. I. Nicholson